Teoxane consent form: Free PDF download and guide

Key Takeaways

A Teoxane consent form documents patient understanding of Teoxane (Teosyal) hyaluronic acid dermal filler procedures before treatment begins.

UK-based aesthetic practitioners must obtain written informed consent that complies with GDPR, JCCP standards, and Save Face guidelines. US practitioners follow FDA and HIPAA requirements.

Essential consent form sections include contraindication screening, risk disclosure (vascular occlusion, allergic reaction, bruising), pre/post-care instructions, and signature fields for both patient and practitioner.

Practice management software like Pabau streamlines consent collection through digital forms and a patient portal, automating the workflow while keeping timestamped compliance documentation ready for audit and regulatory review.

Aesthetic practitioners who administer Teoxane (Teosyal) dermal fillers must obtain informed consent before treatment. A professional Teoxane consent form documents that the patient understands the procedure, its risks, the contraindications, and their aftercare obligations, which protects both the patient and your practice.

Below, you’ll find what a Teoxane consent form must include, how to fit it into your workflow, and how to keep the signed record audit-ready.

What is a Teoxane consent form?

A Teoxane consent form is a legal medical document that confirms a patient has been informed about a Teoxane dermal filler treatment and agrees to proceed with it. Teoxane Laboratories, founded in 2003 and based in Geneva, manufactures Teosyal, a range of hyaluronic acid dermal fillers used for lip augmentation, nasolabial fold treatment, cheek enhancement, and anti-wrinkle correction. Its PureSense and RHA lines are sterile, non-animal hyaluronic acid gels that contain lidocaine to reduce discomfort during injection.

The consent form captures patient acknowledgment of the treatment’s benefits, potential side effects, absolute and relative contraindications, and post-treatment care requirements. Because Teosyal is a hyaluronic acid filler, a hyaluronic acid dermal filler consent form should name the specific product injected rather than relying on generic treatment language.

In the UK, informed consent is a legal and ethical requirement governed by GDPR (data protection), MHRA guidance (medicines safety), and professional standards set by the Joint Council for Cosmetic Practitioners (JCCP) and Save Face accreditation. In the US, the FDA and HIPAA establish similar requirements. Without documented consent, aesthetic practitioners expose their practice to regulatory findings, complaints, and litigation.

How to use a Teoxane consent form in your practice

Integrating a Teoxane consent form into your practice workflow takes six key steps:

1. Pre-consultation: email a digital version or hand the patient a printable copy of the form before their appointment, so they can review it at home. Answer any questions during the consultation phase, before any treatment is booked.
2. Consultation meeting: review the form face-to-face with the patient. Discuss their medical history, contraindications, and any previous filler reactions. Document any deviations from standard aftercare, such as a scheduled event within 48 hours.
3. Patient confirmation: have the patient read and sign the form at least 24 hours before treatment as best practice, and check your insurance policy for minimum waiting periods. Do not accept verbal consent alone.
4. Post-treatment monitoring: keep the patient in the practice for around 30 minutes after injection so you can spot an immediate reaction, such as an early sign of vascular occlusion, and note on the record that this observation period was completed.
5. Digital storage: scan or store the signed form in your practice management system with secure, encrypted access. Digital forms software automates this, so patients complete consent through a secure portal, timestamps are recorded, and the form is encrypted in the patient’s record for audit and compliance review.
6. Retention protocol: keep signed Teoxane consent forms for at least 6 years, in line with UK health-record retention guidance and the HIPAA requirement for consent documentation in the US. Check your state law and professional indemnity insurer, as some require longer. Set a destruction policy for when the retention period expires.

Practice management software like Pabau can streamline this workflow. Patients complete the consent form through a secure patient portal before their appointment. The signed form saves to the patient record with a timestamp, and your team gets an alert confirming completion. That way, no appointment proceeds without documented consent.

What to include in a Teoxane consent form

Like any patient consent form, a Teoxane consent form must cover specific sections to satisfy regulatory bodies and protect your practice. Here are the essential elements:

• Patient identification: full name, date of birth, contact details, and practice ID, so the right patient is consenting
• Treatment description: which Teosyal product is being used (for example, PureSense or RHA), the treatment site, and the expected duration of results. Record the product name, batch or lot number, and expiry date, so each injection is traceable to a specific device
• Contraindications screening: a two-tier structure covering absolute contraindications (pregnancy, breastfeeding, active infections, bleeding disorders) and relative contraindications (anticoagulants and other medications, autoimmune disease, and a known allergy to lidocaine or amide-type local anesthetics, since Teosyal gels contain lidocaine)
• Risk disclosure: common side effects (bruising, swelling, redness, tenderness) and serious rare risks (vascular occlusion, necrosis, allergic reaction, anaphylaxis, granuloma formation, and visual disturbance)
• Pre-treatment instructions: avoid blood thinners, aspirin, alcohol, and strenuous exercise for 24 hours before, and disclose all medications and supplements
• Post-treatment care: avoid facial massage, extreme heat, sun exposure, and strenuous activity for 24 to 48 hours, with a results timeline of 3 to 7 days for full effect
• Practitioner qualifications statement: confirmation that the injector holds relevant qualifications (nurse practitioner, physician assistant, registered nurse with aesthetic training, or physician)
• Patient acknowledgment: a signature line confirming the patient understands the risks and consents freely
• Practitioner signature: the administering clinician signs to confirm consent was explained and obtained
• Date and witness line (optional): some practices have a third party, such as a staff member, witness the signatures for added protection

The form must be written in plain language, avoiding medical jargon where possible. A Teoxane consent form that uses overly technical language fails the regulatory test: patients must genuinely understand what they’re consenting to, not just sign a document they don’t comprehend.

Regulatory compliance context for Teoxane treatments

In the UK, aesthetic practitioners administering dermal fillers must comply with MHRA guidance on medical devices (Teoxane products are CE-marked medical devices) and follow professional standards from the Joint Council for Cosmetic Practitioners.

In the US, the FDA regulates hyaluronic acid dermal fillers as medical devices. Practitioners must obtain informed consent that addresses FDA-recognized risks. HIPAA requires that consent documentation be stored with access controls and breach notification procedures in place.

Many US states require injectors to hold a nursing license, physician credential, or licensed aesthetician status with specific injectable training certification, and the consent form should reference the injector’s credential.

Both systems also expect you to act if something goes wrong. If a patient has a serious reaction, report it to the relevant regulator (the MHRA in the UK or the FDA in the US) and to Teoxane Laboratories as the manufacturer. Recording the batch number on the consent form is what lets you trace the exact product involved.

Common mistakes in Teoxane consent forms

Several consent form pitfalls undermine compliance:

• Generic filler language: a Teoxane consent form that copies generic “dermal filler” wording without naming the Teosyal product used fails to address product-specific risks. Always name the product.
• No batch or lot number: forms that skip the product batch number, lot, and expiry leave you unable to trace which device was injected if a reaction or a manufacturer recall follows. Capture these details at the point of treatment.
• Incomplete contraindication screening: forms that miss relative contraindications, such as patients on anticoagulants, a history of keloid formation, or a known lidocaine allergy, leave you exposed. Since Teosyal gels contain lidocaine, an amide-anesthetic allergy check belongs on the form. Include a detailed medical history questionnaire.
• Ignoring existing filler: injecting over filler from another brand carries added risk, and the interactions are not well studied. Ask the patient what they have had before, and record it.
• Missing signature date: unsigned or undated consent forms are treated as invalid in an audit. Both patient and practitioner signatures must include the date.
• Unclear aftercare: vague post-treatment guidance such as “avoid strenuous activity” lacks specificity. State “avoid strenuous activity for 48 hours” or reference a separate aftercare handout.
• No record of explanation: consent forms should include a practitioner checkbox confirming “I have discussed the above risks and benefits with this patient in person and answered their questions.” This documents that consent was informed, not just read and signed.

Professional consultations paired with structured consent workflows reduce these errors and establish a strong clinical record.

Why a digital consent form matters

Paper consent forms work, but digital Teoxane consent forms offer compliance advantages. When patients complete consent via a secure portal, the system records the timestamp, IP address, and patient confirmation. This creates an auditable trail: regulators can see exactly when and where the patient consented.

AI-assisted clinical documentation can also help practices draft follow-up notes that cross-reference the consent form, ensuring continuity between what the patient agreed to and what the practitioner recorded in the clinical note.

Digital forms also reduce errors: if a patient skips a section (e.g., doesn’t tick the contraindication screening boxes), the form prompts them to complete it before submission. This prevents incomplete consent documentation from entering your system.

Ready to streamline your Teoxane consent workflow? Book a demo with Pabau to see how digital forms integrate with your patient portal, appointment booking, and clinical records in a single platform.

Aftercare guidance to pair with the Teoxane consent form

The Teoxane consent form is the starting point, and aftercare guidance is the follow-through. Many practices pair the consent document with a separate aftercare handout or automated SMS reminders. Patients who receive structured post-treatment instructions (avoid facial massage for 24 hours, no extreme heat or sauna for 48 hours, ice as needed for swelling, avoid alcohol and blood thinners) report fewer adverse reactions and higher satisfaction.

Set expectations about longevity at the same time. Teosyal results typically last 12 to 18 months depending on the product, the treatment area, and the patient’s physiology, and a touch-up session may be needed for the best result. Noting this alongside consent reduces the “why has it worn off?” queries that reach the front desk months later.

Aesthetic EMR software with automated aftercare messaging sends these instructions automatically after each appointment, ensuring consistency and reducing practitioner workload.

Documenting that the patient received and acknowledged aftercare instructions strengthens your compliance record. A Teoxane consent form should reference where aftercare details are provided (printed handout, patient portal, SMS reminder) so the regulatory trail is complete.

See how Pabau keeps Teoxane consent audit-ready

Pabau collects signed Teoxane consent through a secure patient portal before the appointment, timestamps every signature, and files it in the patient record alongside the batch number and treatment note — so there's one place to pull from if a reaction or recall ever follows.

Book a demo

Getting Teoxane consent right

A professional Teoxane consent form is the foundation of safe, legally defensible aesthetic practice. By obtaining informed, written consent that addresses Teoxane-specific risks, contraindications, and aftercare, you protect both your patients and your practice.

The template above includes all the essential sections. Use it as a starting point, customize it to your jurisdiction and the specific Teoxane products you inject, and make sure your team reviews it with every patient before treatment.

Practices that treat consent as a clinical conversation, not just paperwork, build trust and reduce complaints. Ready to automate your consent workflow and free up clinical time? Explore Pabau’s digital forms and how they integrate with your patient records to streamline compliance from first consultation to follow-up.

Continue your research

Treating filler alongside toxin? Botox consent form template covers the neuromodulator side, which needs its own separate consent.

Want a product-agnostic version? Dermal filler consent form template adapts to other hyaluronic acid fillers you inject.

Making consent genuinely informed? Why consultations matter for med spas walks through the pre-treatment discussion behind a valid signature.

Frequently asked questions